Advanced Imaging Guiding Early Sodium-Glucose Cotransporter-2 Inhibitor Therapy: An Outlook to the Future?
J Cardiovasc Pharmacol
.
2023 Oct 1;82(4):281-283.
doi: 10.1097/FJC.0000000000001454.
Authors
Stefano Figliozzi
1
,
Pierre Sabouret
2
3
,
Giuseppe Biondi-Zoccai
4
5
,
Marco Bernardi
6
Affiliations
1
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
2
Heart Institute, Cardiology Department, Pitié-Salpétrière Hospital, Sorbonne University, Paris, France.
3
National College of French Cardiologists, Paris, France.
4
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
5
Mediterranea Cardiocentro, Naples, Italy; and.
6
Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
PMID:
37487240
DOI:
10.1097/FJC.0000000000001454
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Editorial
Comment
MeSH terms
Glucose
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
Substances
Sodium-Glucose Transporter 2 Inhibitors
Glucose
Sodium